Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Paesmans M, Sculier JP, Lecomte J, Thiriaux J, Libert P, Sergysels R, Bureau G, Dabouis G, Van Cutsem O, Mommen P, Ninane V, Klastersky J. Paesmans M, et al. Among authors: sculier jp. Cancer. 2000 Aug 1;89(3):523-33. doi: 10.1002/1097-0142(20000801)89:3<523::aid-cncr7>3.0.co;2-6. Cancer. 2000. PMID: 10931451
A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
Klastersky J, Sculier JP, Dabouis G, Bureau G, Libert P, Ravez P, Vandermoten G, Thiriaux J, Lecomte J, Cordier R, et al. Klastersky J, et al. Among authors: sculier jp. Semin Oncol. 1990 Feb;17(1 Suppl 2):20-4. Semin Oncol. 1990. PMID: 2154855 Clinical Trial.
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
Klastersky J, Sculier JP, Lacroix H, Dabouis G, Bureau G, Libert P, Richez M, Ravez P, Vandermoten G, Thiriaux J, et al. Klastersky J, et al. Among authors: sculier jp. J Clin Oncol. 1990 Sep;8(9):1556-62. doi: 10.1200/JCO.1990.8.9.1556. J Clin Oncol. 1990. PMID: 2167953 Clinical Trial.
Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.
Body JJ, Sculier JP, Raymakers N, Paesmans M, Ravez P, Libert P, Richez M, Dabouis G, Lacroix H, Bureau G, et al. Body JJ, et al. Among authors: sculier jp. Cancer. 1990 Apr 1;65(7):1552-6. doi: 10.1002/1097-0142(19900401)65:7<1552::aid-cncr2820650717>3.0.co;2-d. Cancer. 1990. PMID: 2311066
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Klastersky J, Sculier JP, Ries F, Dabouis G, Libert P, Schmerber J, Thiriaux J, Berchier MC, Bureau G, Van Cutsem O, et al. Klastersky J, et al. Among authors: sculier jp. Lung Cancer. 1994 Dec;11(5-6):373-84. doi: 10.1016/0169-5002(94)92166-0. Lung Cancer. 1994. PMID: 7704494 Clinical Trial.
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
Paesmans M, Sculier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P, et al. Paesmans M, et al. Among authors: sculier jp. J Clin Oncol. 1995 May;13(5):1221-30. doi: 10.1200/JCO.1995.13.5.1221. J Clin Oncol. 1995. PMID: 7738625 Clinical Trial.
435 results